Gurpreet Brar, PhD has a strong background in viral immunology and preclinical studies, with experience working as a Senior Scientist at CEPI, a Postdoctoral Fellow at Sanofi Pasteur and Roche, and as a Postdoctoral Researcher at the University of California, Los Angeles. They have a Doctor of Philosophy (Ph.D.) in Molecular Pharmacology from UCLA and a Bachelor's Degree in Microbiology and Immunology from the University of Washington. Their research focuses on strategic design of prophylactic vaccines for respiratory viruses and tumor associated herpesviruses.
This person is not in any offices